Effect of FK 506 on Epstein-Barr virus specific cytotoxic T cells

This publication has 7 references indexed in Scilit:

• Epstein-Barr Virus-Associated Lymphoproliferative Disorders in Immunocompromised Individuals
  Advances in Cancer Research, 1991
• IMMUNOHISTOLOGY OF EPSTEIN-BARR VIRUS-ASSOCIATED ANTIGENS IN B CELL DISORDERS FROM IMMUNOCOMPROMISED INDIVIDUALS
  Transplantation, 1990
• The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
  The Journal of Immunology, 1989
• FK-506 — How much potential?
  Immunology Today, 1989
• FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.
  The Journal of Antibiotics, 1987
• LONG-TERM T-CELL-MEDIATED IMMUNITY TO EPSTEIN-BARR VIRUS IN RENAL-ALLOGRAFT RECIPIENTS RECEIVING CYCLOSPORIN A
  The Lancet, 1981
• Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. I. Complete regression of virus‐induced transformation in cultures of seropositive donor leukocytes
  International Journal of Cancer, 1978